Publications by authors named "Sarah Spinler"

Claim this Profile
R
Reply: Impact of Remdesivir on Heart Rate and Bradycardia Incidence Among Hospitalized Adults With COVID-19.
Wesley D Kufel, Robert W Seabury, Sarah A Spinler

Ann Pharmacother· February 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Remdesivir on Heart Rate and Bradycardia Incidence Among Hospitalized Adults With COVID-19.
Wesley D Kufel, Zoey J Zagoria, Robert W Seabury, Nabil Zeineddine, Stephen J Thomas, Sarah A Spinler

Ann Pharmacother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preparing NAPLEX-Ready Graduates Requires Collaboration to Optimize Success.
Mary Elizabeth Ray, Thomas M Ellington, Lisa Lebovitz, Sarah A Spinler, Diana M Sobieraj

Am J Pharm Educ· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolving Standards: An Examination of NAPLEX Blueprint Changes and Implications for the Academy.
Diana M Sobieraj, Thomas M Ellington, Aleda M H Chen, Michael P Kelsch, Lisa Lebovitz, Sarah Spinler

Am J Pharm Educ· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a Medication-Use Evaluation Template for Andexanet Alfa in the Reversal of Anticoagulation With Factor Xa Inhibitors.
Toni Fera, Allison Burnett, Jessica Grandoni, Mary R Moore, Barbara B Nussbaum, Sarah A Spinler

J Pharm Pract· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rivaroxaban Versus Apixaban: A Comparison Without a Simple Solution.
Marc Cohen, Alex C Spyropoulos, Shaun G Goodman, Sarah A Spinler, Marc P Bonaca

Mayo Clin Proc Innov Qual Outcomes· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Description of Required NAPLEX Preparation Courses Among US Pharmacy Programs.
Diana M Sobieraj, Aleda M H Chen, Michael P Kelsch, Lisa Lebovitz, Sarah A Spinler

Am J Pharm Educ· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NAPLEX Preparation Program Characteristics and Resources Associated With First-Time Exam Pass Rates.
Diana M Sobieraj, Aleda M H Chen, Michael P Kelsch, Lisa Lebovitz, Sarah A Spinler

Am J Pharm Educ· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sodium-Glucose Cotransporter 2 Inhibitors Among Heart Failure With Mildly Reduced and Preserved Ejection Fraction.
Judy W M Cheng, Vincent Colucci, James S Kalus, Sarah A Spinler

Ann Pharmacother· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Description of NAPLEX and MPJE Preparation Strategies Among US Colleges and Schools of Pharmacy.
Lisa Lebovitz, Aleda M H Chen, Lawrence Carey, Jean T Carter, Michael P Kelsch, Sarah A Spinler

Am J Pharm Educ· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Patients at Risk for and With Left Ventricular Thrombus: A Scientific Statement From the American Heart Association.
Glenn N Levine, John W McEvoy, James C Fang, Chinwe Ibeh, Cian P McCarthy, Sarah A Spinler

Circulation· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 and thrombosis: From bench to bedside.
Mohammad A M Ali, Sarah A Spinler

Trends Cardiovasc Med· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Focused Updates: SGLT2 Inhibitors in Patients With Heart Failure and/or Chronic Kidney Disease.
Judy W M Cheng, Vincent Colucci, James S Kalus, Sarah A Spinler

Ann Pharmacother· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or With Atherosclerotic Cardiovascular Disease: A Report of the American College of Cardiology Solution Set Oversight Committee.
Dharam J Kumbhani, Christopher P Cannon, Craig J Beavers, Deepak L Bhatt, Adam Cuker, Sarah A Spinler

J Am Coll Cardiol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of a formal pharmacy residency research certificate program.
William Darko, Robert W Seabury, Christopher D Miller, Sarah A Spinler, Luke A Probst

Am J Health Syst Pharm· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aspirin for primary prevention of cardiovascular disease: a review of recent literature and updated guideline recommendations.
Amanda Mogul, Emily E Leppien, Elizabeth Laughlin, Sarah A Spinler

Expert Opin Pharmacother· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply: Managing Diabetes and Preventing Heart Disease: Have We Found a Safe and Effective Agent?
Judy W M Cheng, Vincent Colucci, James S Kalus, Sarah A Spinler

Ann Pharmacother· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing Diabetes and Preventing Heart Disease: Have We Found a Safe and Effective Agent?
Judy W M Cheng, Vincent J Colucci, James S Kalus, Sarah A Spinler

Ann Pharmacother· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author's Reply to: Comment: Translating Guidelines Into Practice: Interpreting the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk.
Laura H Waite, Yvonne L Phan, Sarah A Spinler

Ann Pharmacother· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Translating Guidelines Into Practice: Interpreting the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk.
Laura H Waite, Yvonne L Phan, Sarah A Spinler

Ann Pharmacother· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What's next for dyslipidemia management? The 2013 ACC/AHA Guidelines, the NLA recommendations, and beyond.
Laura H Waite, Yvonne L Phan, Sarah A Spinler

J Am Pharm Assoc (2003)· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2017 ACC Expert Consensus Decision Pathway for Periprocedural Management of Anticoagulation in Patients With Nonvalvular Atrial Fibrillation: A Report of the American College of Cardiology Clinical Expert Consensus Document Task Force.
John U Doherty, Ty J Gluckman, William J Hucker, James L Januzzi, Thomas L Ortel, Sarah A Spinler

J Am Coll Cardiol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to: Pharmacology of anticoagulants used in the treatment of venous thromboembolism.
Edith A Nutescu, Allison Burnett, John Fanikos, Sarah Spinler, Ann Wittkowsky

J Thromb Thrombolysis· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacology of anticoagulants used in the treatment of venous thromboembolism.
Edith A Nutescu, Allison Burnett, John Fanikos, Sarah Spinler, Ann Wittkowsky

J Thromb Thrombolysis· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency of Attainment of Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol Goals in Cardiovascular Clinical Practice (from the National Cardiovascular Data Registry PINNACLE Registry).
Sarah A Spinler, Mark J Cziraky, Vincent J Willey, Fengming Tang, Thomas M Maddox

Am J Cardiol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis